-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MR-107A02 in Post-Operative Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MR-107A02 in Post-Operative Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MR-107A02 in Post-Operative Pain Drug Details: MR-107A-02 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (Oxycodone MR + Promethazine IR) in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Oxycodone MR + Promethazine IR) in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Oxycodone MR + Promethazine IR) in Pain Drug Details:...
-
Product Insights
NewNet Present Value Model: Cytokinetics Inc’s Omecamtiv Mecarbil MR
Empower your strategies with our Net Present Value Model: Cytokinetics Inc's Omecamtiv Mecarbil MR report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MR-301 in Traumatic Brain Injury
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. MR-301 in Traumatic Brain Injury Drug Details: MR-301 is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ocedurenone in Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ocedurenone in Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ocedurenone in Hypertension Drug Details: Ocedurenone (KBP-5074) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Amantadine Hydrochloride in Traumatic Brain Injury
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Amantadine Hydrochloride in Traumatic Brain Injury report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amantadine Hydrochloride in Traumatic Brain Injury Drug Details: Amantadine hydrochloride...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ocedurenone in Chronic Kidney Disease (Chronic Renal Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ocedurenone in Chronic Kidney Disease (Chronic Renal Failure) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ocedurenone in Chronic Kidney Disease (Chronic Renal Failure)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MR-148 in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MR-148 in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.MR-148 in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: MR-148 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MR-107A02 in Dental Pain (Toothache/Tooth Pain)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MR-107A02 in Dental Pain (Toothache/Tooth Pain) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.MR-107A02 in Dental Pain (Toothache/Tooth Pain) Drug Details:MR-107A-02 is under development...